Become A Featured Company

Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry

Ryan Allway

March 1st, 2022

News, Top News

Las Vegas, Nevada–(Newsfile Corp. – March 1, 2022) – Digipath, Inc. (OTCQB: DIGP) (“Digipath” or the “Company”), a service-oriented independent analytical testing laboratory, data analytics firm focused on the cannabis and hemp markets is pleased to announce that it has entered into a Validation Agreement (VA) with CASPR Technologies, a leader in smart environmental indoor technology for healthcare and other spaces.

CASPR (Continuous Air & Surface Pathogen Reduction), is intent on entering the cannabis industry with its market leading technology, proven in other verticals including healthcare, transportation, restaurants, education, churches and more. Under the terms of the agreement, Digipath will test and validate the efficacy of CASPR’s technology in botanical applications, specifically cannabis and hemp. CASPR Technologies will be providing Digipath with a proprietary CASPR powered Smart ToteTM, a device which could provide cannabis growers with the ability to mitigate any yeast and mold microbial contamination while drying and curing.

Digipath will provide ongoing testing to verify and validate the results as new developments and products are created. New data will be compared to the tens of thousands of data points compiled by Digipath and kept in the Digipath Data Vault over the past six years. All validation tests will include both PCR and plating to test for microbial contamination as well as analytical tests for any possible effects on cannabinoids and terpenes. Digipath will also complete heavy metals and pesticides analysis to again, insure efficacy of the CASPR device.

“Digipath is honored to participate in the critical validation phase for what could become a game-changing product in the cannabis industry,” stated Digipath Founder and President Todd Denkin. “CASPR is firmly established in other industries as an essential environmental technology company and its potential entry into the cannabis space is long overdue.

“We see cultivators with significant crop losses on a weekly basis due to yeast and mold contamination in our labs that CASPR’s technology could very well mitigate. A system the Smart ToteTM that prevents those losses can most definitely lead to increased profits for cannabis and hemp growers at tremendous scale,” added Denkin.

“Digipath is widely respected as a veteran laboratory with excellent leadership and a truly invaluable body of data in the Digipath Data Vault,” said Dr. Christophe Suchy, CASPR CTO. “They will certainly be a great partner and our gateway to market acceptance and eventual success in the cannabis industry.”

Testing is scheduled to begin this month.

About CASPR:

CASPR (Continuous Air & Surface Pathogen Reduction) Technologies is a leader in smart environmental indoor technology for healthcare and other spaces. Our solutions work to ensure the air we breathe is the healthiest it can be, living out our well-being and enhancing our performance in the process.

Our award-winning, patent pending NCC™ technology proactively and continuously disinfects indoor air and surfaces at the molecular level. Our innovative and proprietary products are low-maintenance, completely automated, and do not depend on pathogens “cycling” through filters to be effective. With CASPR: live, breathe, and work with healthier air and surfaces around the clock. For more information, visit CASPRTech.com.

About Digipath, Inc. (OTCQB: DIGP)

Digipath, Inc., supports the cannabis industry’s best practices for reliable testing, data acquisition, formulations, and new canna-tech to the cannabis industry. The “Digipath Data Vault” is a rich data set of over 70,000 cannabis chemo profiles which can be used for research and product development in a wide variety of applications.

Digipath Labs provides pharmaceutical-grade analysis and testing to the cannabis industry to ensure producers, consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of its clients’ products through analysis, research, development, and standardization.

Information about Forward-Looking Statements

This press release contains “forward-looking statements” that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company’s inability to consummate the closing of the Steep Hill acquisition, need for additional funding, the demand for the Company’s products, governmental regulation of the cannabis industry, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting Digipath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Corporate Contact:
Digipath, Inc.
702-527-2060

Investor Relations & Financial Media

Integrity Media
team@integritymedia.com
Toll Free: (888) 216-3595
www.IntegrityMedia.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading